系统审查:与炎症性肠病相关的耻辱感
Suprabhat Giri1, Sidharth Harindranath2, Sanjay Chandnani3
1Department of Gastroenterology and Hepatology, Kalinga Institute of Medical Sciences, Bhubaneswar, India.
Alimentary pharmacology & therapeutics
|November 4, 2025
概括
耻辱显著影响炎症性肠病 (IBD) 患者,影响生活质量和治疗. 通过提高认识和支持来解决耻辱是改善患者结果和弹性至关重要的.
科学领域:
- 胃肠病学 胃肠病学
- 心理学 心理学 心理学
- 公共卫生 公共卫生
背景情况:
- 耻辱感,包括感知,执行和内化形式,对于患有炎症性肠病 (IBD) 的人来说是一个重要的问题.
- 这种耻辱会对患者的生活质量产生负面影响,延迟必要的医疗治疗,并破坏社会互动.
- 了解IBD耻辱的多面性质对于开发有效的干预措施至关重要.
研究的目的:
- 对与炎症性肠病 (IBD) 相关的耻辱现有研究进行全面审查.
- 总结有关IBD流行,评估方法,促成因素和耻辱的后果的数据.
主要方法:
- 在包括MEDLINE,Embase和Scopus在内的主要数据库中进行了系统的文献搜索.
- 搜索涵盖了报告IBD患者患病率,评估,预测因素和耻辱的结果的研究,从数据库的开始到2025年9月.
- 总共分析了73项研究,以综合IBD污名的发现.
主要成果:
- 由于缺乏标准化尺度,在耻辱评价方法中存在显著的异质性.
- 感知到的耻辱感非常普遍,影响到85.6%的成年人和87%的儿童患有IBD.
- 耻辱表现为对判断的恐惧,对身体形象的担忧,人际关系的困难和工作场所的歧视,报告的行为和内化耻辱率较低.
结论:
- 审查强调了需要标准化研究方法来准确评估IBD的耻辱感.
- 提高公众对IBD的认识和知识对于减少耻辱至关重要.
- 建议采取专注于增强患者性和应对机制的干预措施,以减轻耻辱的负面影响.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
626
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
626
Inflammatory Bowel Disease I: Ulcerative Colitis
882
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
882
Chronic Bowel Disorders: Introduction
739
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
739
Inflammatory Bowel Disease II: Crohn's Disease
943
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
943
Inflammatory Bowel Disease IV: Pharmacological Management
463
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
463
Irritable Bowel Syndrome I: Introduction
905
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
905


